These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28147361)

  • 21. Pharmacokinetics and synovial fluid concentrations of flurbiprofen enantiomers in horses: chiral inversion.
    Soraci AL; Tapia O; Garcia J
    J Vet Pharmacol Ther; 2005 Feb; 28(1):65-70. PubMed ID: 15720517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of in vivo pharmacokinetic behaviors of R- and S-flurbiprofen after intravenous injection of flurbiprofen axetil.
    He Y; Qin M; Li M; Zhi D; Tian B; Qin F
    Chirality; 2023 Apr; 35(4):247-255. PubMed ID: 36759185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intravenous lithium chloride and assessment of agreement between two methods of lithium concentration measurement in the horse.
    Martin LM; Bukoski AD; Whelchel DD; Evans TJ; Wiedmeyer CE; Black SJ; Johnson PJ
    Equine Vet J; 2018 Jul; 50(4):537-543. PubMed ID: 29112289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective pharmacokinetics of flurbiprofen and formation of covalent adducts with plasma protein in adjuvant-induced arthritic rats.
    Nagao T; Tanino T; Iwaki M
    Chirality; 2003 May; 15(5):423-8. PubMed ID: 12692887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased lithium disposition to cerebrospinal fluid in rats with glycerol-induced acute renal failure.
    Sakae R; Ishikawa A; Niso T; Komori Y; Aiba T; Kawasaki H; Kurosaki Y
    Pharm Res; 2008 Oct; 25(10):2243-9. PubMed ID: 18581208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselectivity of biliary excretion of 2-arylpropionates in rats.
    Menzel S; Beck WS; Brune K; Geisslinger G
    Chirality; 1993; 5(6):422-7. PubMed ID: 8398601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of the enantiomers of ibuprofen and flurbiprofen on the beta-oxidation of palmitate in the rat.
    Zhao B; Geisslinger G; Hall I; Day RO; Williams KM
    Chirality; 1992; 4(3):137-41. PubMed ID: 1586584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the in vitro glucuronidation of flurbiprofen enantiomers.
    Hamdoune M; Mounie J; Magdalou J; Masmoudi T; Goudonnet H; Escousse A
    Drug Metab Dispos; 1995 Mar; 23(3):343-8. PubMed ID: 7628299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral and/or central effects of racemic-, S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord.
    Buritova J; Besson JM
    Br J Pharmacol; 1998 Sep; 125(1):87-101. PubMed ID: 9776348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enantioselective disposition of clenbuterol in rats.
    Hirosawa I; Ishikawa M; Ogino M; Ito H; Hirao T; Yamada H; Asahi M; Kotaki H; Sai Y; Miyamoto K
    Biopharm Drug Dispos; 2014 May; 35(4):207-17. PubMed ID: 24323748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status.
    Knadler MP; Brater DC; Hall SD
    J Pharmacol Exp Ther; 1989 May; 249(2):378-85. PubMed ID: 2724130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of flurbiprofen and aspirin on acetazolamide disposition in humans.
    Sweeney KR; Chapron DJ; Antal EJ; Kramer PA
    Br J Clin Pharmacol; 1989 Jun; 27(6):866-9. PubMed ID: 2757898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
    Radwan MA; Aboul-Enein HY
    Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2-COX-1 selectivity on urinary sodium and potassium excretion in the rat.
    Harirforoosh S; Jamali F
    Can J Physiol Pharmacol; 2005 Jan; 83(1):85-90. PubMed ID: 15759054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselective pharmacokinetics of flobufen in rats.
    Trejtnar F; Wsol V; Szotakova B; Skalova L; Pavek P; Kuchar M
    Chirality; 1999; 11(10):781-6. PubMed ID: 10561708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foscarnet, an inhibitor of the sodium-phosphate cotransporter NaPi-IIa, inhibits phosphorylation of glycogen synthase kinase-3β by lithium in the rat kidney cortex.
    Uwai Y; Kawasaki T; Nabekura T
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):256-9. PubMed ID: 27238574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.
    Abas A; Meffin PJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):637-41. PubMed ID: 3806417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Haghani M
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1191-201. PubMed ID: 21164566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the capacity of the rat intestine to excrete lithium ions at therapeutic and toxic plasma lithium concentrations.
    Erbil Y; Eroglu L; Forth W; Schmolke G; Elsenhans B; Schümann K
    J Trace Elem Electrolytes Health Dis; 1993 Jun; 7(2):95-9. PubMed ID: 8219751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic lithium treatment protects the rat kidney against ischemia/reperfusion injury: the role of nitric oxide and cyclooxygenase pathways.
    Talab SS; Emami H; Elmi A; Nezami BG; Assa S; Deroee AF; Daneshmand A; Tavangar SM; Dehpour AR
    Eur J Pharmacol; 2010 Nov; 647(1-3):171-7. PubMed ID: 20826134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.